ITCC-058 ATEZOLIZUMAB
A phase I/II, multicenter, open-label study of the safety and pharmacokinetics of anti-pd-l1 antibody (MPDL3280A) in pediatric and young adult patients with previously treated solid tumors
Promotor Name : HOFFMAN LA ROCHE
Investigator Name : B. GEOERGER
Trial registered on clinicaltrial.gov: NCT02541604
